Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy : an economic evaluation based on data from the LENS trial

Scotland, G, Tsehaye, M, Styles, C, Logue, J, Sammons, E, Zayed, M, Emberson, J, Wade, R, Wallendszus, K, Stevens, W, Cretney, R, Harding, S, Leese, G, Currie, G, Armitage, J, Preiss, D & LENS collaborative group 2025, 'Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy : an economic evaluation based on data from the LENS trial', Diabetic Medicine, vol. 42, no. 9, e70098. https://doi.org/10.1111/dme.70098